Clinical trials
Hodgkin Disease trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asan Medical Center | 3 |
| Samsung Medical Center | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Accenture | 1 |
| AstraZeneca | 1 |
| National Cancer Center, Korea | 1 |
| Novartis Pharmaceuticals | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 13 |
| Lymphoma, Non-Hodgkin | 7 |
| Lymphoma | 6 |
| Recurrence | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Multiple Myeloma | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Blast Crisis | 3 |
| Burkitt Lymphoma | 3 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.